The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
Abstract
The potential to block tumor growth by inhibition of the neoangiogenic process represents an intriguing approach to the treatment of solid tumors. The high proliferation rate in the tumor deprived of proper vascularization would be balanced by cell death due to lack of diffusion of nutrients and oxygen. Matrix metalloproteinases (MMPs), angiogenic growth factors, and their receptors are the main targets of an increasing number of clinical trials approved to test the tolerance and therapeutic efficacy of antiangiogenic agents. We observed that a series of substances proposed as possible cancer chemopreventive agents show antiangiogenic properties when tested in in vitro and in vivo angiogenesis models. We demonstrated that N‐acetyl ‐L ‐cysteine is able to reduce the invasive and metastatic potential of melanoma cells, and to inhibit endothelial cell invasion by direct inhibition of MMP activity. We also showed that epigallocatechin gallate (EGCG), a flavonoid from green tea that possesses chemopreventive activity in experimental and epidemi‐ological studies, is a potent inhibitor of MMP‐2 and MMP‐9. Angiogenesis has also been demonstrated to be a target for nonsteroidal anti‐inflammatory drug che‐mopreventive activity. Based on these data, we hypothesize that other chemopreventive agents, including natural or synthetic retinoids, steroid hormone antagonists, peroxisome proliferator‐activated receptor γ li‐gands, vitamin D, and protease inhibitors, might have antiangiogenesis as an important mechanism of action, a novel concept we will term ‘angioprevention’. We analyze the mechanisms on how and why chemopreven‐tive agents could exert antiangiogenic effects aimed at controlling tumor growth, and their potential use in the clinic.—Tosetti, F., Ferrari, N., De Flora, S., Albini, A. ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J. 16, 2–14 (2002)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Antioxidant and redox regulation of gene transcription
Sen, C. K., & Packer, L. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.7.8635688 · Cited by 1,981
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Isolation of a tumor factor responsible for angiogenesis
Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Oxidants as Stimulators of Signal Transduction
Suzuki, Y. J., Forman, H. J., & Sevanian, A. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00275-4 · Cited by 1,369
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255 · cited 1×
“However, a carotenoid ( -carotene) was shown to significantly increase the mortality for primary lung tumors in smokers and asbestos-exposed individuals (78).”
BackgroundSuperoxide and hydrogen peroxide in relation to mammalian cell proliferation
Burdon, R. H. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)00198-s · Cited by 1,173
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., & Tarnawski, A. S. (1999) · Nature Medicine · doi:10.1038/70995 · Cited by 827
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Henderson, B. E., & Feigelson, H. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.427 · Cited by 821
Genistein, a dietary-derived inhibitor of in vitro angiogenesis.
Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., & Schweigerer, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2690 · Cited by 766
Irani, K. (2000) · Circulation Research · doi:10.1161/01.res.87.3.179 · Cited by 748
Why drinking green tea could prevent cancer
Jankun, J., Selman, S. H., Swiercz, R., & Skrzypczak-Jankun, E. (1997) · Nature · doi:10.1038/42381 · Cited by 718
Angiogenesis inhibited by drinking tea
Cao, Y., & Cao, R. (1999) · Nature · doi:10.1038/18793 · Cited by 688
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
Hwang, D., Byrne, J., Scollard, D., & Levine, E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.455 · Cited by 651
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.3.co;2-# · Cited by 609
Goldberg, M. A., & Schneider, T. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41787-x · Cited by 572
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., & Fidler, I. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204535 · Cited by 556
Retinoic acid is a negative regulator of AP-1-responsive genes.
Schüle, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L. J., Bolado, J., Verma, I. M., & Evans, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6092 · Cited by 526
The AP-1 site and MMP gene regulation: What is all the fuss about?
Benbow, U., & Brinckerhoff, C. E. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90026-3 · Cited by 520
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo
Nam, S., Smith, D. M., & Dou, Q. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004209200 · Cited by 504
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
1α,25-Dihydroxyvitamin D 3 Inhibits Angiogenesis In Vitro and In Vivo
Mantell, D. J., Owens, P. E., Bundred, N. J., Mawer, E. B., & Canfield, A. E. (2000) · Circulation Research · doi:10.1161/01.res.87.3.214 · Cited by 454
Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive Agents
Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., et al. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.467s · Cited by 441
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
Gallo, O., Fini-Storchi, I., Vergari, W. A., Masini, E., Morbidelli, L., Ziche, M., & Franchi, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.587 · Cited by 427
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Kuroki, M., Voest, E. E., Amano, S., Beerepoot, L. V., Takashima, S., Tolentino, M., Kim, R. Y., Rohan, R. M., Colby, K. A., Yeo, K. T., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118962 · Cited by 423
Veronesi, U., De Palo, G., Marubini, E., Costa, A., Formelli, F., Mariani, L., Decensi, A., Camerini, T., Del Turco, M. R., Di Mauro, M. G., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1847 · Cited by 419
Proteases in invasion: matrix metalloproteinases
Stetler-Stevenson, W. G., & Yu, A. E. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0365 · Cited by 411
VEGF: an update on biological and therapeutic aspects
Ferrara, N. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00153-1 · Cited by 372
Nicholson, R. C., Mader, S., Nagpal, S., Leid, M., Rochette-Egly, C., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07895.x · Cited by 370
Tea and Tea Polyphenols in Cancer Prevention
Yang, C. S., Chung, J. Y., Yang, G.-Y., Chhabra, S. K., & Lee, M.-J. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.472s · Cited by 367
INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
LIU, X. H., KIRSCHENBAUM, A., YAO, S., LEE, R., HOLLAND, J. F., & LEVINE, A. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67321-1 · Cited by 363
De Flora, S., Izzotti, A., D'Agostini, F., & Balansky, R. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.999 · Cited by 351
Self-citationMerke, J., Milde, P., Lewicka, S., Hügel, U., Klaus, G., Mangelsdorf, D. J., Haussler, M. R., Rauterberg, E. W., & Ritz, E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114097 · Cited by 341
Reduced Risk of Esophageal Cancer Associated With Green Tea Consumption
Gao, Y. T., McLaughlin, J. K., Blot, W. J., Ji, B. T., Dai, Q., & Fraumeni, J. F. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.855 · Cited by 339
Jung, Y. D., Kim, M. S., Shin, B. A., Chay, K. O., Ahn, B. W., Liu, W., Bucana, C. D., Gallick, G. E., & Ellis, L. M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1691 · Cited by 329
Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade
Lin, J.-K., Liang, Y.-C., & Lin-Shiau, S.-Y. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00112-4 · Cited by 324
Perspectives on Cancer Chemoprevention Research and Drug Development
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61026-x · Cited by 317
Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate
Garbisa, S., Sartor, L., Biggin, S., Salvato, B., Benelli, R., & Albini., A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<822::aid-cncr1070>3.0.co;2-g · Cited by 316
Self-citationProtection against breast cancer with genistein: a component of soy
Lamartiniere, C. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1705s · Cited by 314
Helen, K., Greg Peterson, T., & Barnes, S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1418s · Cited by 309
Kennedy, A. R. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00010-2 · Cited by 305
Genistein exerts multiple suppressive effects on human breast carcinoma cells.
Shao, Z. M., Wu, J., Shen, Z. Z., & Barsky, S. H. (1998) · PubMed · Cited by 304
Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients
Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., & Higashi, Y. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00556.x · Cited by 303
Da Silva, J., Pierrat, B., Mary, J.-L., & Lesslauer, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28373 · Cited by 301
Holtmann, H., Winzen, R., Holland, P., Eickemeier, S., Hoffmann, E., Wallach, D., Malinin, N. L., Cooper, J. A., Resch, K., & Kracht, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6742 · Cited by 295
Liang, Y.-C., Lin-shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971001)67:1<55::aid-jcb6>3.0.co;2-v · Cited by 294
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10868 · Cited by 292
Rak, J. W., Mitsuhashi, Y., Sheehan, C., Tamir, A., Viloria‐Petit, A., Filmus, J., Mansour, S. J., Ahn, N. G., & Kerbel, R. S. (2000) · PubMed · Cited by 288
Kong, A.-N. T., Yu, R., Chen, C., Mandlekar, S., & Primiano, T. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02976458 · Cited by 274
Shono, T., Ono, M., Izumi, H., Jimi, S.-I., Matsushima, K., Okamoto, T., Kohno, K., & Kuwano, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4231 · Cited by 274
Hyder, S. M., Nawaz, Z., Chiappetta, C., & Stancel, G. M. (2000) · PubMed · Cited by 268
Hsu, T.-C., Young, M. R., Cmarik, J., & Colburn, N. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00220-3 · Cited by 265
Gorman, A. A., & Rodgers, M. A. J. (1981) · Chemical Society Reviews · doi:10.1039/cs9811000205 · Cited by 260
Angiogenesis and prostate cancer: identification of a molecular progression switch.
Huss, W. J., Hanrahan, C. F., Barrios, R. J., Simons, J. W., & Greenberg, N. M. (2001) · PubMed · Cited by 253
Na, S.-Y., Kang, B. Y., Chung, S. W., Han, S.-J., Ma, X., Trinchieri, G., Im, S.-Y., Lee, J. W., & Kim, T. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7674 · Cited by 233
Yen, L., You, X.-L., Al Moustafa, A.-E., Batist, G., Hynes, N. E., Mader, S., Meloche, S., & Alaoui-Jamali, M. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203685 · Cited by 230
Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells
Chua, C. C., Hamdy, R. C., & Chua, B. H. L. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00115-4 · Cited by 221
Miele, C., Rochford, J. J., Filippa, N., Giorgetti-Peraldi, S., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000805200 · Cited by 216
Maurer, B. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1897 · Cited by 215
Green Tea and the Risk of Gastric Cancer in Japan
Tsubono, Y., Nishino, Y., Komatsu, S., Hsieh, C.-C., Kanemura, S., Tsuji, I., Nakatsuka, H., Fukao, A., Satoh, H., & Hisamichi, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440903 · Cited by 213
Joseph, I. B. J., Nelson, J. B., Denmeade, S. R., & Isaacs, J. T. (1997) · PubMed · Cited by 211
Antiangiogenic Activity of Prostate-Specific Antigen
Fortier, A. H., Nelson, B. J., Grella, D. K., & Holaday, J. W. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1635 · Cited by 210
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Gottardis, M. M., Bischoff, E. D., Shirley, M. A., WAGONER, M., Lamph, W. W., & Heyman, R. A. (1996) · PubMed · Cited by 199
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata, T., He, S., Hangai, M., Ishibashi, T., Xi, X. P., Kim, S., Hsueh, W. A., Ryan, S. J., Law, R. E., & Hinton, D. R. (2000) · PubMed · Cited by 196
Cancer Chemoprevention: Progress and Promise
Lippman, S. M., Lee, J. J., & Sabichi, A. L. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1514 · Cited by 194
Katiyar, S. K., Challa, A., McCormick, T. S., Cooper, K. D., & Mukhtar, H. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2117 · Cited by 193
Singlet Molecular Oxygen (1O2): A Possible Effector of Eukaryotic Gene Expression
Ryter, S. W., & Tyrrell, R. M. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00461-9 · Cited by 192
Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells
Narvaez, C. J., & Welsh, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006876200 · Cited by 189
Bergelson, S., Pinkus, R., & Daniel, V. (1994) · PubMed · Cited by 187
Yue, T.-L., Wang, X., Louden, C. S., Gupta, S., Pillarisetti, K., Gu, J.-L., Hart, T. K., Lysko, P. G., & Feuerstein, G. Z. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.951 · Cited by 187
‘Accidental’ anti-angiogenic drugs
Kerbel, R. S., Viloria-Petit, A., Klement, G., & Rak, J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00092-7 · Cited by 182
Zhou, J.-R., Mukherjee, P., Gugger, E. T., Tanaka, T., Blackburn, G. L., & Clinton, S. K. (1999) · The Journal of Urology · doi:10.1097/00005392-199908000-00098 · Cited by 181
Steele, V. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.1.63 · Cited by 179
Tumor invasion: molecular shears blunted by green tea
Garbisa, S., Biggin, S., Cavallarin, N., Sartor, L., Benelli, R., & Albini, A. (1999) · Nature Medicine · doi:10.1038/15145 · Cited by 174
Self-citationAhn, H.-Y., Hadizadeh, K. R., Seul, C., Yun, Y.-P., Vetter, H., & Sachinidis, A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.1093 · Cited by 173
Yu, G.-P., Hsieh, C.-C., Wang, L.-Y., Yu, S.-Z., Li, X.-L., & Jin, T.-H. (1995) · Cancer Causes and Control · doi:10.1007/bf00054162 · Cited by 173
Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin
Dong, Z., Huang, C., Brown, R. E., & Ma, W.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9962 · Cited by 170
STEWART, R. J., PANIGRAHY, D., FLYNN, E., & FOLKMAN, J. (2001) · Journal of Urology · doi:10.1097/00005392-200102000-00095 · Cited by 164
Evidence that nitric oxide is an endogenous antiangiogenic mediator
Pipili‐Synetos, E., Sakkoula, E., Haralabopoulos, G., Andriopoulou, P., Peristeris, P., & Maragoudakis, M. E. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14822.x · Cited by 163
Strasly, M., Cavallo, F., Geuna, M., Mitola, S. M. F., Colombo, M. P., Forni, G., & Bussolino, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3890 · Cited by 156
MESTRE, J. R., Subbaramaiah, K., Sacks, P. G., Schantz, S. P., Tanabe, T., Inoue, H., & Dannenberg, A. J. (1997) · PubMed · Cited by 155
Rudek, M. A., Figg, W. D., Dyer, V., Dahut, W. L., Turner, M. L. C., Steinberg, S. M., Liewehr, D. J., Köhler, D., Pluda, J. M., & Reed, E. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.584 · Cited by 153
Chinery, R., Beauchamp, R. D., Shyr, Y., Kirkland, S. C., Coffey, R. J., & Morrow, J. D. (1998) · PubMed · Cited by 149
Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen
Heidtmann, H.-H., Nettelbeck, D. M., Mingels, A., Jäger, R., Welker, H.-G., & Kontermann, R. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6692167 · Cited by 148
Erdreich‐Epstein, A., Shimada, H., Groshen, S. G., Liu, M., Metelitsa, L. S., Kim, K., Stins, M. F., Seeger, R. C., & Durden, D. L. (2000) · PubMed · Cited by 148
Signaling Angiogenesis via p42/p44 MAP Kinase Cascade
Pagès, G., Milanini, J., Richard, D. E., Berra, E., Gothié, E., Viñals, F., & Pouysségur, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06313.x · Cited by 143
Armstrong, W. B., Kennedy, A. R., Wan, X. S., Taylor, T. H., Nguyen, Q. A., Jensen, J., Thompson, W., Lagerberg, W., & Meyskens, F. L. (2000) · PubMed · Cited by 137
Advances in the Development of Retinoids as Chemopreventive Agents
Lippman, S. M., & Lotan, R. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.479s · Cited by 129
Jiang, C., Agarwal, R., & Lü, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3474 · Cited by 128
Janssen-Heininger, Y. M. W., Heintz, N. H., & Mossman, B. T. (1995) · PubMed · Cited by 128
Majewski, S., Szmurło, A., Marczak, M., Jabłońska, S., & Bollag, W. B. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570115 · Cited by 121
Butticè, G., Quiñones, S., & Kurkinen, M. T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.13.3723 · Cited by 120
Albini, A., D’Agostini, F., Giunciuglio, D., Paglieri, I., Balansky, R. M., & Flora, S. D. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610121 · Cited by 120
Self-citationThe antiangiogenic agent TNP-470 requires p53 and p21 CIP/WAF for endothelial cell growth arrest
Yeh, J.-R. J., Mohan, R., & Crews, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12782 · Cited by 120
Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids
Vega-Diaz, B., Lenoir, M.-C., Ladoux, A., Frelin, C., Démarchez, M., & Michel, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.642 · Cited by 116
Zhao, J., Sharma, Y., & Agarwal, R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199912)26:4<321::aid-mc11>3.0.co;2-9 · Cited by 107
N-acetylcysteine inhibits endothelial cell invasion and angiogenesis.
Cai, T., Fassina, G., Morini, M., Aluigi, M. G., Masiello, L., Fontanini, G., D’Agostini, F., Flora, S. D., Noonan, D. M., & Albini, A. (1999) · PubMed · Cited by 106
Self-citationVitamin D inhibits angiogenesis in transgenic murine retinoblastoma.
Shokravi, M., Marcus, D. M., Alroy, J., Egan, K. M., Saornil, M. A., & Albert, D. M. (1995) · PubMed · Cited by 103
Lee, O.-H., Bae, S. K., Bae, M., Lee, Y. M., Moon, E., J, H., Kwon, Y., & Kim, K. W. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0931 · Cited by 99
Sun, S., Yue, P., & Lotan, R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12164-5 · Cited by 99
Gniadecki, R. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12348498 · Cited by 96
Suppression of Nerve Growth Factor-induced Neuronal Differentiation of PC12 Cells
Kamata, H., Tanaka, C., Yagisawa, H., Matsuda, S., Gotoh, Y., Nishida, E., & Hirata, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33018 · Cited by 91
Schroen, D. J., & Brinckerhoff, C. (1996) · Europe PMC (PubMed Central) · Cited by 91
Folkman, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.94 · Cited by 90
Braunhut, S. J., & Moses, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36856-4 · Cited by 89
Lansink, M., Koolwijk, P., van Hinsbergh, V. W. M., & Kooistra, T. (1998) · Blood · doi:10.1182/blood.v92.3.927 · Cited by 88
Lingen, M. W., Polverini, P. J., & BOUCK, N. P. (1996) · PubMed · Cited by 88
Yao, L., Pike, S. E., Setsuda, J., Parekh, J. R., Gupta, G. D., Raffeld, M. A., Jaffe, E. S., & Tosato, G. (2000) · Blood · doi:10.1182/blood.v96.5.1900 · Cited by 86
Modulation of Interferon Action by Retinoids
Weihua, X., Kolla, V., & Kalvakolanu, D. V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9742 · Cited by 83
Hyder, S. M., Chiappetta, C., & Stancel, G. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1236 · Cited by 79
Uckun, F. M., Messinger, Y. H., Chen, C., O'Neill, K., Myers, D. E., Goldman, F. D., Hurvitz, C. G., Casper, J. T., & Levine, A. (1999) · PubMed · Cited by 75
Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic.
Lingen, M. W., Polverini, P. J., & Bouck, N. (1996) · Europe PMC (PubMed Central) · Cited by 73
Majewski, S., Marczak, M., Szmurło, A., Jabłońska, S., & Bollag, W. B. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03662-3 · Cited by 72
Bischoff, E. D., Heyman, R. A., & Lamph, W. W. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2118 · Cited by 65
Growth factor-dependent induction of p21CIP1 by the green tea polyphenol, epigallocatechin gallate
Liberto, M., & Cobrinik, D. E. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00378-5 · Cited by 64
Prostate cancer prevention trials in the USA
Brawley, O. W., & Parnes, H. L. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00105-2 · Cited by 63
Redondo, P., Bandrés, E., Solano, T., Okroujnov, I., & García‐Foncillas, J. (2000) · Cytokine · doi:10.1006/cyto.1999.0566 · Cited by 62
Li, W., Dehnade, F., & Zafarullah, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3385 · Cited by 54
Sk, B., Zoubine, M. N., Dk, S., et al. (2000) · PubMed · Cited by 54
Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer
DeCensi, A., & Costa, A. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00040-x · Cited by 53
Kaposi sarcoma is a therapeutic target for vitamin D3receptor agonist
Masood, R., Nagpal, S., Zheng, T. Z., Cai, J., Tulpule, A., Smith, D. L., & Gill, P. S. (2000) · Blood · doi:10.1182/blood.v96.9.3188 · Cited by 49
Park, B. H., Breyer, B. N., & He, T. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200101000-00015 · Cited by 44
Bertolini, F., Fusetti, L., Rabascio, C., Cinieri, S., Martinelli, G., & Pruneri, G. (2000) · Leukemia · doi:10.1038/sj.leu.2401854 · Cited by 44
Role of Basement Membrane in Tumor Growth and Metastasis
Kleinman, H. K., Koblinski, J. E., Lee, S. D., & Engbring, J. A. (2001) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30068-1 · Cited by 42
THOMPSON, E. A., Nelles, L., & Collen, D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16323.x · Cited by 41
Multiple Regulatory Elements in the Murine Stromelysin-3 Promoter
Ludwig, M., Basset, P., & Anglard, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007529200 · Cited by 40
Nargi‐Aizenman, J. L., Ratan, R. R., & Griffin, D. E. (1999) · Neoplasia · doi:10.1038/sj.neo.7900068 · Cited by 37
Beta interferon inhibits HIV-1 tat-induced angiogenesis: synergism with 13- cis retinoic acid
Iurlaro, M., Benelli, R., Masiello, L., Rosso, M., Santi, L., & Albini, A. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10082-x · Cited by 35
Self-citationFenretinide and cancer prevention
Torrisi, R., & DeCensi, A. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0077-x · Cited by 28
Protease inhibitors in oral carcinogenesis and chemoprevention.
Lippman, S. M., & Matrisian, L. M. (2000) · PubMed · Cited by 28
Lewis, M., Amento, E. P., & Unemori, E. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990301)72:3<373::aid-jcb7>3.0.co;2-n · Cited by 25
New Oral Chemotherapeutic Agents for Lung Cancer
Bengtson, E. M., & Rigas, J. R. (1999) · Drugs · doi:10.2165/00003495-199958003-00009 · Cited by 12
Cited by
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Benavente-García, O., & Castillo, J. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8006568 · Cited by 1,158
Flavonoids: Promising anticancer agents
Ren, W., Qiao, Z., Wang, H., Zhu, L., & Zhang, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10033 · Cited by 1,150
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2067 · Cited by 823
Self-citationAnti-cancer potential of flavonoids: recent trends and future perspectives
Batra, P., & Sharma, A. K. (2013) · 3 Biotech · doi:10.1007/s13205-013-0117-5 · Cited by 550
Metadata
- Authors
- Tosetti, F., Ferrari, N., De Flora, S., & Albini, A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 16
- Issue
- 1
- Pages
- 2-14
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2084796179
- Cited by
- 324
- References
- 147
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.